ExosomeDx Webinars & Urology Resources
-
Beyond PSA: Utility of a Urine Gene Expression Assay for Early Prostate Cancer Detection
In this webinar, Dr. John Smith and Dr. Albala explore the breakthrough ExoDx™ Prostate Test, a non-invasive risk assessment tool for prostate cancer. They discuss its accuracy and ability to guide treatment decisions, highlighting its potential to revolutionize prostate cancer management. -
Smarter Management of Prostate Cancer: The Five W’s of Utilizing a Liquid Biopsy Approach
Join Dr. Kasraeian for this discussion on the “5 W’s” of Liquid Biopsy approaches, including Who, What, Why Where, and When to use liquid biopsy testing to improve management of prostate cancer. -
Entering the Chat Room of Cancer Cells - How They Talk and Why We Should Listen
Small exosome packages act as communication vehicles between cells, much like todays Twitter messages and by intercepting this communication we can now listen in on the cells language to detect cancer earlier as well as see how cancer is changing over time. -
Detection of MISEV recommended EV Protein-Markers using Automated Western Blotting
In this video, ExosomeDx lead researcher, Lisa Meyer walks us through a newly developed workflow for detecting MISEV recommended extracellular vesicle (EV) protein markers using automated western blotting. -
How the ExoDx Prostate Test Impacts Urology Practice in a Real-World Clinical Setting
The study demonstrated that EPI delivered improved patient outcomes over standard of care in a real-world clinical setting that included 72 urologists, 24 sites and more than 1000 patients. -
ExoDx™ Prostate Test - A Solution to Address Fear of the Prostate Biopsy Decision
Recent findings from a real-world clinical study underscore how EPI supports clinical decision making and motivate sometimes unwilling patients to proceed to or defer prostate biopsy. In addition, this tool was proven to detect more high-grade prostate cancers over standard of care parameters alone. -
ExoDx Prostate Test: Implications for Value-Based Care
Dr. Judd Moul address practical challenges in prostate cancer risk assessment, and speaks on how The ExoDx™ Prostate Test combats these challenges from a clinical perspective. -
Beyond PSA: The ExoDx Prostate™ test (EPI) as a Precision Genomic Biomarker
Dr. David M. Albala, Chief of Urology at Crouse Hospital in Syracuse, New York, explores the novel ExoDx Prostate™ and the growing demand for diagnostic tools that provide prognostic information to identify the right patient to undergo biopsy at the right time. -
The Power of Exosomes: Diagnostic Applications and Beyond
Learn more about exosomes in our webinar with Dr. Skog, one of the first scientists to discover exosomes. He will provide an overview of exosomes, dynamics and physiology, exosomes as mediators of infectious disease, therapeutics and diagnostics.